Abich Financial Wealth Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$55.6K Buy
+4,758
New +$62K 0.02% 303
2024
Q3
$5.49K Buy
243
+180
+286% +$3.72K 0.01% 251
2024
Q2
$1.23K Buy
63
+58
+1,160% +$1.52K ﹤0.01% 570
2024
Q1
$188 Buy
+5
New +$220 ﹤0.01% 488

Other funds holding TXG

Abich Financial Wealth Management's TXG Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in 10x Genomics (TXG) in Q3 2025: 4,758 shares worth $55.6K. The stake represents 0.02% of the portfolio and ranks #303 among its holdings. This is a return to the name: Abich Financial Wealth Management previously reported a position in TXG as recently as Q3 2024.

Abich Financial Wealth Management first reported a position in TXG in Q1 2024 and has held it in 4 quarters since. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • Abich Financial Wealth Management held 4,758 shares of 10x Genomics worth $55.6K as of Q3 2025.
  • 10x Genomics was a new Abich Financial Wealth Management position in Q3 2025.
  • 10x Genomics made up 0.02% of Abich Financial Wealth Management's portfolio in Q3 2025, its #303 holding.
  • Abich Financial Wealth Management first reported a position in 10x Genomics in Q1 2024 and has held it in 4 quarters since.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.